Strongest US Cough/Cold Season In 10 Years Likely
Sales Growth For US OTC Firms May Not Offset Inflation, Exchange Headwinds, Though
Increasing numbers cough/cold drug prescriptions combined with consumers’ waning interest in flu vaccines point to 2022-2023 season rivaling decade-high levels from 2017-18 and to retailers boosting inventories through year-end, Raymond James analysts say.
